Lancet Neurology

The Lancet is a weekly peer-reviewed general medical journal. It is one of the world s best known, oldest, and most respected general medical journals. The Lancet was founded in 1823 by Thomas Wakley, an English surgeon who named it after the surgical instrument called a lancet, as well as after the term "lancet arch", a window with a sharp pointed arch, to indicate the "light of wisdom" or "to let in light". It publishes original research articles, review articles ("seminars" and "reviews"), editorials, book reviews, correspondence, as well as news features and case reports. The Lancet has been owned by Elsevier since 1991. As of 1995, the editor-in-chief is Richard Horton. The journal has editorial offices in London, New York, and Beijing. In the 2010 Journal Citation Reports, The Lancet s impact factor was ranked second among general medical journals, at 33.63, after The New England Journal of Medicine (53.48). The Lancet also has several speciality journals all bearing the parent title: The Lancet Neurology (neurology), The Lancet Oncology (oncology), and The Lancet Infectious Diseases (infectious diseases), all of which publish original research and reviews. These three

Publisher
Elsevier
History
1823–present
Website
http://www.thelancet.com/journals/lancet/issue/current
Impact factor
33.633 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Neuroscience

New evidence for a blood-based biomarker for Alzheimer's disease

A potential blood-based biomarker for Alzheimer's and other neurodegenerative diseases seems even more promising thanks to new research from a Massachusetts General Hospital-led study. According to this team's work, neurofilament ...

Neuroscience

New blood test for Alzheimer's developed

A new blood test for Alzheimer's disease has been developed under the leadership of researchers at the University of Gothenburg. The method is based on measuring a specific variant of tau protein in ordinary blood samples, ...

Neuroscience

A potential treatment for life-threatening neurological diseases

A group of life-threatening neurological conditions affecting children has been linked to an antibody that points to potential treatment, according to an observational multicenter study involving 535 children with central ...

Medical research

Paralysed man walks again with brain-controlled exoskeleton

A French man paralysed in a night club accident can walk again thanks to a brain-controlled exoskeleton in what scientists said Wednesday was a breakthrough providing hope to tetraplegics seeking to regain movement.

page 1 from 14